BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 19660042)

  • 1. Effect of smoking, abstention, and nicotine patch on epidermal healing and collagenase in skin transudate.
    Sørensen LT; Zillmer R; Agren M; Ladelund S; Karlsmark T; Gottrup F
    Wound Repair Regen; 2009; 17(3):347-53. PubMed ID: 19660042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of smoking, smoking cessation, and nicotine patch on wound dimension, vitamin C, and systemic markers of collagen metabolism.
    Sørensen LT; Toft BG; Rygaard J; Ladelund S; Paddon M; James T; Taylor R; Gottrup F
    Surgery; 2010 Nov; 148(5):982-90. PubMed ID: 20347467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smoking attenuates wound inflammation and proliferation while smoking cessation restores inflammation but not proliferation.
    Sørensen LT; Toft B; Rygaard J; Ladelund S; Teisner B; Gottrup F
    Wound Repair Regen; 2010; 18(2):186-92. PubMed ID: 20163570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of smoking and abstention on oxidative burst and reactivity of neutrophils and monocytes.
    Sørensen LT; Nielsen HB; Kharazmi A; Gottrup F
    Surgery; 2004 Nov; 136(5):1047-53. PubMed ID: 15523399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdermal nicotine patch enhances type I collagen synthesis in abstinent smokers.
    Sørensen LT; Jorgensen LN; Zillmer R; Vange J; Hemmingsen U; Gottrup F
    Wound Repair Regen; 2006; 14(3):247-51. PubMed ID: 16808802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-8 is the predominant collagenase in healing wounds and nonhealing ulcers.
    Nwomeh BC; Liang HX; Cohen IK; Yager DR
    J Surg Res; 1999 Feb; 81(2):189-95. PubMed ID: 9927539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A transdermal nicotine patch is not effective for postoperative pain management in smokers: a pilot dose-ranging study.
    Olson LC; Hong D; Conell-Price JS; Cheng S; Flood P
    Anesth Analg; 2009 Dec; 109(6):1987-91. PubMed ID: 19923530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of matrix metalloproteinase-2, -9 and -8 in the skin, serum and saliva of smokers and non-smokers.
    Raitio A; Tuomas H; Kokkonen N; Salo T; Sorsa T; Hanemaaijer R; Oikarinen A
    Arch Dermatol Res; 2005 Dec; 297(6):242-8. PubMed ID: 16215764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers.
    Shiffman S; Sweeney CT; Ferguson SG; Sembower MA; Gitchell JG
    Clin Ther; 2008 Oct; 30(10):1852-8. PubMed ID: 19014840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute reduction in secretory immunoglobulin A following smoking cessation.
    Ussher M; West R; Evans P; Steptoe A; McEwen A; Clow A; Hucklebridge F
    Psychoneuroendocrinology; 2004 Nov; 29(10):1335-40. PubMed ID: 15288713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.
    Kleykamp BA; Jennings JM; Sams C; Weaver MF; Eissenberg T
    Exp Clin Psychopharmacol; 2008 Apr; 16(2):99-112. PubMed ID: 18489014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of smoking on the pharmacokinetics and pharmacodynamics of a nicotine patch.
    Yun HY; Seo JW; Choi JE; Baek IH; Kang W; Kwon KI
    Biopharm Drug Dispos; 2008 Dec; 29(9):521-8. PubMed ID: 19054833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quitting by gradual smoking reduction using nicotine gum: a randomized controlled trial.
    Shiffman S; Ferguson SG; Strahs KR
    Am J Prev Med; 2009 Feb; 36(2):96-104.e1. PubMed ID: 19135903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking.
    Rohsenow DJ; Monti PM; Hutchison KE; Swift RM; MacKinnon SV; Sirota AD; Kaplan GB
    Exp Clin Psychopharmacol; 2007 Feb; 15(1):81-92. PubMed ID: 17295587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precessation treatment with nicotine patch significantly increases abstinence rates relative to conventional treatment.
    Rose JE; Herskovic JE; Behm FM; Westman EC
    Nicotine Tob Res; 2009 Sep; 11(9):1067-75. PubMed ID: 19567826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds.
    Agren MS; Mirastschijski U; Karlsmark T; Saarialho-Kere UK
    Exp Dermatol; 2001 Oct; 10(5):337-48. PubMed ID: 11589731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transdermal nicotine during imaginal exposure to anxiety and smoking cues in college smokers.
    Morissette SB; Palfai TP; Gulliver SB; Spiegel DA; Barlow DH
    Psychol Addict Behav; 2005 Jun; 19(2):192-8. PubMed ID: 16011390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking, cortisol and nicotine.
    Steptoe A; Ussher M
    Int J Psychophysiol; 2006 Mar; 59(3):228-35. PubMed ID: 16337291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine dependence, psychological distress and personality traits as possible predictors of smoking cessation. Results of a double-blind study with nicotine patch.
    Cosci F; Corlando A; Fornai E; Pistelli F; Paoletti P; Carrozzi L
    Addict Behav; 2009 Jan; 34(1):28-35. PubMed ID: 18804918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.